— Know what they know.
Not Investment Advice
Also trades as: 0IV3.L (LSE) · $vol 0M

GERN NASDAQ

Geron Corporation
1W: -10.0% 1M: -18.7% 3M: -33.0% YTD: -4.5% 1Y: -9.3% 3Y: -58.5% 5Y: -6.0%
$1.28
+0.02 (+1.59%)
 
Weekly Expected Move ±8.3%
$1 $1 $1 $1 $2
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 28 · $821.1M mcap · 536M float · 3.43% daily turnover · Short 50% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$184M +138.8% ▲
5Y CAGR: +273.5%
Gross Profit
$179M +136.5% ▲
Operating Income
-$54M +69.0% ▲
Net Income
-$86M +50.9% ▲
EPS (Diluted)
$-0.13 +51.9% ▲
EBITDA
-$52M +66.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1M$596K$237K$77M$184M
YoY Growth+450.6%-57.2%-60.2%+32386.9%+138.8%
Cost of Revenue$0$0$0$1M$5M
Gross Profit$1M$596K$237K$76M$179M
Gross Margin100.0%100.0%100.0%98.4%97.4%
R&D Expenses$86M$96M$125M$104M$74M
SG&A Expenses$30M$44M$69M$146M$159M
Operating Expenses$115M$139M$194M$249M$233M
Operating Income-$114M-$139M-$194M-$174M-$54M
Operating Margin-8183.7%-23246.6%-81832.9%-225.6%-29.3%
Interest Expense$4M$7M$8M$19M$33M
Income Before Tax-$116M-$142M-$184M-$175M-$86M
Tax Expense$0$0$0$0$0
Net Income-$116M-$142M-$184M-$175M-$86M
Net Margin-8335.4%-23808.9%-77690.7%-226.7%-46.7%
EPS (Diluted)$-0.37$-0.37$-0.32$-0.27$-0.13
EBITDA-$112M-$134M-$175M-$155M-$52M
Shares Outstanding328M381M571M646M667M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms